OQROGet OQRO Pro
Insider trade

Ventas (VTR)Director sold ~$104K

Walter C Rakowich, Director at Ventas, sold ~$104K of Ventas shares.

~$104K
Approx. value · 1,152 sh @ $90.20
28K
Holds after · shares reported
Traded
May 14, 2026
Filed
May 15, 2026

The story around this disclosure

Every dated public record OQRO holds about the company from 60 days before to 120 days after, oldest first. It shows what was going on; none of it is a stated reason for the trade.

  1. Mar 27, 20265% stakeThe Vanguard Group reported a passive stake (13G)
  2. Mar 27, 2026CongressDisclosed purchase of VTR — reported range $1,001 - $15,000
  3. Apr 27, 2026Company filing · Form 8-K · ResultsReported its results
  4. Apr 29, 20265% stakeVanguard Portfolio Management reported a passive stake (13G) of 8.7%
  5. Apr 30, 20265% stakeVanguard Capital Management reported a passive stake (13G) of 7.5%
  6. May 4, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 7.1%
  7. May 12, 2026Company filing · Form 8-K · Executive change, Shareholder voteChanged a top executive or board member, and held a shareholder vote (and 1 more item)“On May 12, 2026, in connection with his previously disclosed retirement on May 1, 2026, Ventas, Inc. (the “Company”) entered into a separation and release agreement with Peter J. Bulgarelli, Executive Vice President, Outpatient Medical & Research, Ventas, Inc. and President and CEO, Lillibridge Healthcare Services, Inc. (the “Separation Agreement”), pursuant to which Mr. Bulgarelli will receive a payment equal to…”
  8. May 12, 20265% stakeJPMORGAN CHASE & CO reported a passive stake (13G) of 7.1%
  9. May 14, 2026 · this disclosureInsiderDirector sold ~$104K of VTR shares in the open market

What came next

  1. Jun 3, 2026Insider · 12 days before an 8-KDirector purchased ~$197K of VTR shares in the open market
  2. Jun 15, 2026Company filing · Form 8-K · Executive change, Other newsChanged a top executive or board member, and reported other company news“On June 15, 2026, Carey S. Roberts, Executive Vice President, General Counsel, Ethics & Compliance Officer and Corporate Secretary of Ventas, Inc. (“Ventas” or the “Company”) notified Ventas of her intention to resign from the Company effective June 26, 2026 (the “Effective Date”).”
  3. Jul 27, 20265% stakeJPMORGAN CHASE & CO. reported a passive stake (13G) of 8.7%
  4. Jul 29, 2026Company filing · Form 8-K · ResultsReported its results
View the official recordSEC Form 4

How to read SEC Form 4

Form 4 is the filing that officers, directors and owners of more than 10% of a US-listed company must send to the SEC within two business days after they buy, sell or otherwise change their holding of the company's stock.

Full guide: What is an SEC Form 4?

What else is on file for Ventas

For Ventas, OQRO holds 1 Congress trade report and 16 fund holdings reports (13F) dated in the last 90 days.

These are records OQRO holds, counted by their date, not a measure of how much trading took place. Routine paperwork such as option exercises and tax withholding is left out. Everything for the company is on its VTR page.

Other recent filings by Walter C Rakowich, Director

The full history of Walter C Rakowich, Director is on the profile page.

How this filing works

Other disclosures at Ventas

Everything OQRO holds on this company is on its VTR page.

This is one filing. OQRO holds the rest

Insider trades filed with the SEC, stock trades disclosed by members of Congress, fund holdings from 13F filings and federal contract awards, each one in plain words next to its official filing. On this page it opens why the trade stands out, what the company did around that time, the price since, and every field of the form.

Unlock OQRO ProAlready have an account? Log in

OQRO Pro is a paid subscription. You see the price before you pay

OQRO describes public disclosures and context calculated from them. It does not give personalized advice and does not recommend any transaction. How OQRO treats data